Mickaël J Y Ploquin

Title: The Innovations of Mickaël J Y Ploquin

Introduction

Mickaël J Y Ploquin is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical research, particularly in the study of HIV and its progression. With a total of 2 patents, his work focuses on identifying biomarkers that can predict the progression of HIV.

Latest Patents

Mickaël's latest patents include innovative methods for identifying patients capable of controlling HIV progression. One of his inventions, titled "Levels of CXCL10/IP-10 forms and soluble CD26/DPPIV activity as early predictive biomarkers for HIV/SIV associated mucosal inflammation and progression towards AIDS," provides methods for the identification of patients who can manage their HIV effectively. This invention also identifies an antagonist form of IP-10 associated with HIV progression control, which can improve the immunological response of HIV patients.

Career Highlights

Throughout his career, Mickaël has worked with prestigious institutions such as Institut Pasteur and Assistance Publique-Hôpitaux de Paris. His research has been pivotal in advancing our understanding of HIV and its effects on the immune system.

Collaborations

Mickaël has collaborated with esteemed colleagues, including Michaela Müller-Trutwin and Matthew Albert. These partnerships have further enriched his research and contributed to the development of his patents.

Conclusion

Mickaël J Y Ploquin's work exemplifies the intersection of innovation and healthcare. His contributions to HIV research through his patents are invaluable in the ongoing fight against this disease.